GlassScriptPhysician profile
Lori M Silva
NPI 1891925327
$814.71
in general payments reported to CMS, 2019-2025
8 companies · $762 in 2025
The $762 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.35 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirum Pharmaceuticals, INC. | $291.63 | 2025 | Livmarli |
| Madrigal Pharmaceuticals | $141.11 | 2025 | Rezdiffra |
| Scpharmaceuticals INC. | $134.53 | 2025 | |
| Lilly USA, LLC | $124.98 | 2025 | Mounjaro |
| Novo Nordisk INC | $52.35 | 2021 | |
| Dynavax Technologies Corporation | $29.27 | 2025 | Heplisav-B |
| Cipher Pharmaceuticals US LLC | $25.61 | 2025 | Natroba, Spinosad |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.23 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.